Your browser doesn't support javascript.
SARS-CoV-2 variants and ending the COVID-19 pandemic.
Fontanet, Arnaud; Autran, Brigitte; Lina, Bruno; Kieny, Marie Paule; Karim, Salim S Abdool; Sridhar, Devi.
  • Fontanet A; Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris 75015, France; Conservatoire National des Arts et Métiers, PACRI Unit, Paris, France. Electronic address: fontanet@pasteur.fr.
  • Autran B; Sorbonne-Université, Paris, France; UMR-S Inserm/UPMC 1135, CIMI-Paris (Centre de Recherches Immunité Maladies Infectieuses), Paris, France.
  • Lina B; CNR des Virus des Infections Respiratoires, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France; Virpath, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, CNRS UMR5308, École Normale Supérieure de Lyon, UCBL, Lyon, France.
  • Kieny MP; Inserm, Paris, France.
  • Karim SSA; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
  • Sridhar D; Usher Institute of Population Health Sciences and Informatics, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
Lancet ; 397(10278): 952-954, 2021 03 13.
Article in English | MEDLINE | ID: covidwho-1078238

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Disease Control / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Disease Control / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article